Dr Yassir Osama Mahgoub, MD | |
2501 North Third St, Harrisburg, PA 17110-1904 | |
(717) 782-6420 | |
(717) 782-4727 |
Full Name | Dr Yassir Osama Mahgoub |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 17 Years |
Location | 2501 North Third St, Harrisburg, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043659121 | NPI | - | NPPES |
1036376270001 | Medicaid | PA |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Milton S Hershey Medical Center Physicians Group | 3870405483 | 1400 |
News Archive
Scientists from the UK Defence Science and Technology Laboratory (Dstl) report, in a preliminary study, that they have demonstrated that a single dose of Aradigm Corporation's liposomal ciprofloxacin formulation Lipoquin administered 24 hours after exposure to a lethal dose of the bacterium Yersinia pestis provided full protection in a murine model of pneumonic plague.
Citing uncertainties about the risks and benefits of an experimental therapy for fetuses whose kidneys do not develop, bioethicists at Johns Hopkins and a team of medical experts are calling for rigorous clinical trials in the use of a potential treatment, known as amnioinfusion.
Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza, on Thursday dismissed allegations that the agency exaggerated the threat of the H1N1 (swine flu) pandemic and has been influenced by the pharmaceutical industry, the Washington Post reports.
The Bend Memorial Clinic is recruiting patients for a Phase III lung cancer trial aimed at preventing the disease's recurrence in previously treated patients. Specifically, the trial is evaluating the potential of an immunotherapy called Antigen-Specific Cancer Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung Cancer (NSCLC).
› Verified 8 days ago
Entity Name | The Milton S Hershey Medical Center Physicians Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
Scientists from the UK Defence Science and Technology Laboratory (Dstl) report, in a preliminary study, that they have demonstrated that a single dose of Aradigm Corporation's liposomal ciprofloxacin formulation Lipoquin administered 24 hours after exposure to a lethal dose of the bacterium Yersinia pestis provided full protection in a murine model of pneumonic plague.
Citing uncertainties about the risks and benefits of an experimental therapy for fetuses whose kidneys do not develop, bioethicists at Johns Hopkins and a team of medical experts are calling for rigorous clinical trials in the use of a potential treatment, known as amnioinfusion.
Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza, on Thursday dismissed allegations that the agency exaggerated the threat of the H1N1 (swine flu) pandemic and has been influenced by the pharmaceutical industry, the Washington Post reports.
The Bend Memorial Clinic is recruiting patients for a Phase III lung cancer trial aimed at preventing the disease's recurrence in previously treated patients. Specifically, the trial is evaluating the potential of an immunotherapy called Antigen-Specific Cancer Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung Cancer (NSCLC).
› Verified 8 days ago
Entity Name | Pennsylvania Psychiatric Institute |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1881829976 PECOS PAC ID: 3870678915 Enrollment ID: O20091112000465 |
News Archive
Scientists from the UK Defence Science and Technology Laboratory (Dstl) report, in a preliminary study, that they have demonstrated that a single dose of Aradigm Corporation's liposomal ciprofloxacin formulation Lipoquin administered 24 hours after exposure to a lethal dose of the bacterium Yersinia pestis provided full protection in a murine model of pneumonic plague.
Citing uncertainties about the risks and benefits of an experimental therapy for fetuses whose kidneys do not develop, bioethicists at Johns Hopkins and a team of medical experts are calling for rigorous clinical trials in the use of a potential treatment, known as amnioinfusion.
Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza, on Thursday dismissed allegations that the agency exaggerated the threat of the H1N1 (swine flu) pandemic and has been influenced by the pharmaceutical industry, the Washington Post reports.
The Bend Memorial Clinic is recruiting patients for a Phase III lung cancer trial aimed at preventing the disease's recurrence in previously treated patients. Specifically, the trial is evaluating the potential of an immunotherapy called Antigen-Specific Cancer Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung Cancer (NSCLC).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Yassir Osama Mahgoub, MD Po Box 858, Mc A410, Hershey, PA 17033-0858 Ph: (800) 243-1455 | Dr Yassir Osama Mahgoub, MD 2501 North Third St, Harrisburg, PA 17110-1904 Ph: (717) 782-6420 |
News Archive
Scientists from the UK Defence Science and Technology Laboratory (Dstl) report, in a preliminary study, that they have demonstrated that a single dose of Aradigm Corporation's liposomal ciprofloxacin formulation Lipoquin administered 24 hours after exposure to a lethal dose of the bacterium Yersinia pestis provided full protection in a murine model of pneumonic plague.
Citing uncertainties about the risks and benefits of an experimental therapy for fetuses whose kidneys do not develop, bioethicists at Johns Hopkins and a team of medical experts are calling for rigorous clinical trials in the use of a potential treatment, known as amnioinfusion.
Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza, on Thursday dismissed allegations that the agency exaggerated the threat of the H1N1 (swine flu) pandemic and has been influenced by the pharmaceutical industry, the Washington Post reports.
The Bend Memorial Clinic is recruiting patients for a Phase III lung cancer trial aimed at preventing the disease's recurrence in previously treated patients. Specifically, the trial is evaluating the potential of an immunotherapy called Antigen-Specific Cancer Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung Cancer (NSCLC).
› Verified 8 days ago
Dr. Valentyna Honchar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4250 Crums Mill Rd Ste 102, Harrisburg, PA 17112 Phone: 717-649-0211 Fax: 206-895-7032 | |
Dr. Daisy Shirk, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2501 N 3rd St, Harrisburg, PA 17110 Phone: 717-782-4734 Fax: 717-782-4727 | |
Rahat Taswir, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2209 Forest Hills Dr, Suite 19, Harrisburg, PA 17112 Phone: 717-540-4420 Fax: 717-540-4427 | |
Nuzhat Kausar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2595 Interstate Dr, Suite 103, Harrisburg, PA 17110 Phone: 800-370-3651 Fax: 860-510-0020 | |
Ray E Sharretts, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 409 S 2nd St, Suite 3f, Harrisburg, PA 17104 Phone: 717-123-0345 Fax: 717-230-3411 | |
Paul A Conti, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 307 S Front St, Harrisburg, PA 17104 Phone: 717-221-6200 Fax: 717-221-6208 |